See more : Metal Sky Star Acquisition Corporation (MSSAW) Income Statement Analysis – Financial Results
Complete financial analysis of Binah Capital Group, Inc. (BCG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Binah Capital Group, Inc., a leading company in the Asset Management industry within the Financial Services sector.
- Unichem Laboratories Limited (UNICHEMLAB.BO) Income Statement Analysis – Financial Results
- Medicover AB (publ) (0RPS.L) Income Statement Analysis – Financial Results
- POCL Enterprises Limited (POEL.BO) Income Statement Analysis – Financial Results
- Innovest Global, Inc. (IVST) Income Statement Analysis – Financial Results
- Great Canadian Gaming Corporation (GC.TO) Income Statement Analysis – Financial Results
Binah Capital Group, Inc. (BCG)
About Binah Capital Group, Inc.
Binah Capital Group, Inc., together with its subsidiaries, operates in the wealth management industry. The company provides access to stock, bond, exchange-traded fund, and options execution services; and research, compliance, supervision, and accounting and related services for financial advisors. It also offers mutual funds and insurance products, as well as alternative investments, such as non-traded real estate investment trusts, unit trusts, and fixed and variable annuities. The company was founded in 2016 and is headquartered in Albany, New York. Binah Capital Group, Inc. operates as a subsidiary of MHC Securities, LLC.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 159.86M | 172.40M | 167.28M | 110.43M |
Cost of Revenue | 149.55M | 161.40M | 154.99M | 101.34M |
Gross Profit | 10.31M | 11.00M | 12.29M | 9.09M |
Gross Profit Ratio | 6.45% | 6.38% | 7.34% | 8.23% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 7.17M | 7.03M | 5.02M | 6.35M |
Selling & Marketing | -1.27M | 1.89M | -3.81M | -6.15M |
SG&A | 5.90M | 8.92M | 1.21M | 198.78K |
Other Expenses | 0.00 | -3.72M | -2.34M | -1.54M |
Operating Expenses | 8.36M | 8.92M | 1.21M | 198.78K |
Cost & Expenses | 159.13M | 170.32M | 1.21M | 198.78K |
Interest Income | 8.10M | 6.45M | 4.18M | 2.99M |
Interest Expense | 5.12M | 3.32M | 2.87M | 2.61M |
Depreciation & Amortization | 1.22M | 1.52M | 1.64M | 2.22M |
EBITDA | 6.82M | 6.33M | -1.21M | 1.06M |
EBITDA Ratio | 4.27% | 2.09% | -0.72% | -0.18% |
Operating Income | 734.00K | 2.08M | -1.21M | -198.78K |
Operating Income Ratio | 0.46% | 1.21% | -0.72% | -0.18% |
Total Other Income/Expenses | -248.00K | -593.00K | -2.45M | 841.45K |
Income Before Tax | 486.00K | 1.49M | -445.74K | -792.59K |
Income Before Tax Ratio | 0.30% | 0.86% | -0.27% | -0.72% |
Income Tax Expense | -85.00K | 580.00K | -781.45K | -372.50K |
Net Income | 571.00K | 911.00K | -445.74K | -792.59K |
Net Income Ratio | 0.36% | 0.53% | -0.27% | -0.72% |
EPS | 0.43 | 0.06 | -0.03 | -0.05 |
EPS Diluted | 0.43 | 0.06 | -0.03 | -0.05 |
Weighted Avg Shares Out | 1.33M | 16.13M | 14.48M | 14.48M |
Weighted Avg Shares Out (Dil) | 1.33M | 16.13M | 14.48M | 14.48M |
Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
PKS Investments, a Subsidiary of Binah Capital Group, Recognized as One of Albany's Best Places to Work
Over 50% Indians More Confident About Using AI At Work: Boston Report
Binah Capital Group, Inc. Announces Receipt of Nasdaq Non-Compliance Notice
Binah Capital Group Celebrates Successful Completion of Public Listing with Opening Bell Ringing Ceremony at Nasdaq
Why Is Binah Capital (BCG) Stock Up 93% Today?
Source: https://incomestatements.info
Category: Stock Reports